课题基金 / 基金详情

Genomic integrity of the X chromosome & Ovary-Specific Autosomal Genes

Genomic integrity of the X chromosome & Ovary-Specific Autosomal Genes
X 染色体的基因组完整性
批准号:
8840981
负责人:
ALEKSANDAR RAJKOVIC
金额:
$22.98万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-05-01 至 2016-04-30

项目摘要

项目成果

ALEKSANDAR RAJKOVIC的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Primordial follicle pool depletion is the cause of primary ovarian insufficiency (POI) in most women. POI afflicts 1-2% of women, and genetics contributes as much as 70% to POI. Besides infertility, women with POI are at increased risk for osteoporosis, cardiovascular morbidity and mortality. Currently only karyotype and FMR1 pre-mutation testing are offered to women with POI. Fertility preservation is currently feasible for women at risk for losing ovarian function, yet there is a great need for robust and better biomarkers capable of predicting ovarian insufficiency. We are interested in identifying genetic biomarkers that associate with POI. The role of the X chromosome and candidate autosomal genes implicated from knockout animal models has been hypothesized for a long time in the etiology of human POI, yet there is little to show at the gene level. We constructed a novel high-resolution genomic array that interrogates the X chromosome and 134 candidate autosomal gene copy numbers. We show that this array can detect genomic imbalances as small as 500 base pairs, and is superior to commercial arrays. We hypothesize that pathologic genomic imbalances involving the X chromosome and candidate autosomal loci, will be present in more than 10% of women who suffer POI. Moreover, we will sequence the X-chromosome exomes, as well as the exomes of 134 candidate autosomal genes to define contribution of pathogenic mutations to POI. Our proposal will test the relevance of our targeted approach in identifying pathogenic mutations in women with POI, and will stimulate further research into the feasibility of such targeted approaches to predict ovarian failure. Proposed studies may identify novel pathways, and provide future directions for basic science investigations relevant to human POI.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Origin and Cellular Heterogeneity of Uterine Leiomyomas
  • 批准号:
    10613377
  • 项目类别:
  • 资助金额:
    $44.21万
  • 财政年份:
    2019
  • 负责人:
    ALEKSANDAR RAJKOVIC
  • 依托单位:
The Origin and Cellular Heterogeneity of Uterine Leiomyomas
  • 批准号:
    10153843
  • 项目类别:
  • 资助金额:
    $44.21万
  • 财政年份:
    2019
  • 负责人:
    ALEKSANDAR RAJKOVIC
  • 依托单位:
The Origin and Cellular Heterogeneity of Uterine Leiomyomas
  • 批准号:
    10396487
  • 项目类别:
  • 资助金额:
    $44.21万
  • 财政年份:
    2019
  • 负责人:
    ALEKSANDAR RAJKOVIC
  • 依托单位:
Med12 mechanisms of uterine leiomyoma formation
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: